Screen time in childhood and adolescence is positively associated with higher cardiometabolic risk, supported by consistent ...

Navi Mumbai News: 22-Year-Old UP Migrant Drowns After Fishing Boat Capsizes Near Mora Jetty; 9 Others Swim To Safety According to preliminary information, the boat was out at sea for repair work ...

- Poster presentation of updated data on BT-001 from the Phase 1 part of the ongoing Phase 1/2a study in solid tumors - LUND, SE / ACCESS Newswire / July 28, 2025 / BioInvent International AB ...

BT-001 is being co-developed as part of a 50/50 collaboration on oncolytic viruses between Transgene and BioInvent. In the Phase 1 part of this study, as monotherapy and in combination with MSD's anti ...

Poster presentation of updated data on BT-001 from the Phase I part of the ongoing Phase I/IIa study in solid tumors Strasbourg, France, and Lund, Sweden, July 28, 2025, 8:30 a.m. CEST - Transgene ...

Semantic communication (SC) is an emerging intelligent paradigm, offering solutions for various future applications like metaverse, mixed reality, and the Internet of everything. However, in current ...

Morarit Panificatie Roman's average daily volume (3m) is 0.5 thousand. View Morarit Panificatie Roman SA's Average Daily Volume (3m) trends, charts, and more.

Multimodal signals, including text, audio, image, and video, can be integrated into semantic communication (SC) systems to provide an immersive experience with low latency and high quality at the ...

The global LUMUS Phase 2b trial is a randomized, double-blind, placebo-controlled study evaluating multiple doses of ESK-001 in adults with moderately-to-severely active, autoantibody-positive SLE.

The need for Spanish-speaking therapists is urgent. The Latino population in the U.S. is growing, and with it, the demand for mental health care. Lehigh University wants to be part of the solution.

Alumis is a late-stage biopharma company developing next-generation targeted therapies with the potential to significantly improve patient health and outcomes across a range of immune-mediated ...